Research Paper Volume 17, Issue 5 pp 1313—1327
Updated efficacy and safety of CDK4/6 inhibitors plus endocrine therapy in elderly women with HR+/HER-2 metastatic or advanced breast cancer: patient-level network meta-analysis
Figure 2. SUCRA plot of CDK 4/6 efficacy ranking for progression free survival vs. overall survival.